Center for Innovation and Research Organization
Philadelphia, Pennsylvania, 19107, United States
NCT Number: NCT05608382
The objective of this study is simulate the clinical use of an antiseptic solution in a 24 hour window and the recovery to baseline conditions at 1 month following application. Efficacy will be simulated as the capacity of the material to reduce or clear the skin bacterial population from a representative skin area: the anteromedial forearm.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19107, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A subject may be eligible for study participation if all of the following criteria are met:
Exclusion criteria
control group
active comparator
Time frame: 5 minutes
Comparison of the number of CFUs counted for each treatment arm
Time frame: 2 hours
Comparison of the number of CFUs counted for each treatment arm
Time frame: 24 hours
Comparison of the number of CFUs counted for each treatment arm
Center for Innovation and Research Organization
Network
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03487549
Common Wart, Communicable Diseases
Little Rock, Arkansas, United States
View Trial DetailsNCT03981822
Communicable Diseases, Condylomata Acuminata
Plainfield, Indiana, United States
View Trial DetailsNCT04485676
Bacterial Infections, Bacterial Infections and Mycoses
A Coruña, Spain
View Trial DetailsNCT03643952
Bacteremia, Bacterial Infections
Nagoya, Aichi-ken, Japan
View Trial Details